SILVANI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 186
EU - Europa 88
AS - Asia 49
AF - Africa 1
Totale 324
Nazione #
US - Stati Uniti d'America 185
IE - Irlanda 35
IT - Italia 28
SG - Singapore 19
CN - Cina 14
HK - Hong Kong 12
FI - Finlandia 5
FR - Francia 4
DE - Germania 3
KR - Corea 3
RU - Federazione Russa 3
UA - Ucraina 3
BE - Belgio 2
GB - Regno Unito 2
CA - Canada 1
NG - Nigeria 1
NL - Olanda 1
NO - Norvegia 1
SE - Svezia 1
TR - Turchia 1
Totale 324
Città #
Chandler 36
Dublin 35
Houston 20
Singapore 16
Boardman 15
Hong Kong 12
San Mateo 12
Falls Church 8
Ann Arbor 7
Beijing 7
Altamura 6
Lawrence 6
Medford 6
Princeton 6
Santa Clara 6
Andover 4
Wilmington 4
Cambridge 3
Des Moines 3
Perugia 3
Redmond 3
Redwood City 3
Seoul 3
Brussels 2
Dallas 2
Genoa 2
Helsinki 2
Jacksonville 2
Milan 2
Norwalk 2
Paris 2
Seriate 2
Berlin 1
Brescia 1
Den Haag 1
Edinburgh 1
Figline Valdarno 1
Izmir 1
Lagos 1
Los Angeles 1
Nanjing 1
Pescara 1
Saint Petersburg 1
Savona 1
Selargius 1
Simi Valley 1
Toronto 1
Totale 257
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 102
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 62
The first-generation phosphodiesterase 5 inhibitors and their pharmacokinetic issue 50
Intralesional Injection of Hyaluronic Acid in Patients Affected With Peyronie's Disease: Preliminary Results From a Prospective, Multicenter, Pilot Study 46
Corporoplasty Using Buccal Mucosa Graft in Peyronie Disease: Is It a First Choice? 46
Overview of potential determinants of radical prostatectomy versus radiation therapy in management of clinically localized prostate cancer: Results from an Italian, prospective, observational study (the Pros-IT CNR study) 41
Totale 347
Categoria #
all - tutte 1.557
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.557


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 0 0 0 0 0 0 0 0 3 6 2 4
2020/202129 2 6 0 2 13 0 1 3 0 1 1 0
2021/202257 1 8 0 1 1 4 2 14 4 1 5 16
2022/2023116 7 23 1 10 8 13 0 6 41 0 4 3
2023/202453 5 1 6 2 0 2 10 2 0 2 11 12
2024/202531 4 8 8 2 9 0 0 0 0 0 0 0
Totale 347